Short Bowel Syndrome Market - Growth, Future Prospects and Competitive Analysis, Industry Forecast 2016 – 2025
Short Bowel Syndrome Market - Growth, Future Prospects and Competitive Analysis, Industry Forecast 2016 – 2025
(firmenpresse) - According to the latest report published by Credence Research, Inc. 017 to 2025.
Market Insights
Short bowel syndrome is a group of complex diseases that occurs due to malfunction of a portion of small and/or large intestine. The individuals with short bowel syndrome exhibit poor absorption of nutrients such as water, fats, carbohydrates, vitamins, minerals and other vital elements which leads to malnutrition, weight loss. However, in some cases, short bowel syndrome can lead to severe, disabling and life-threatening complications. There is no particular cure to this disorder however surgical removal (resection) of half or more of the small intestine is effective. Short bowel syndrome can lead to Crohnterms of drug in the short bowel syndrome market as it is marketed in U.S. and Europe under the brand name Gattex and Revestive in Europe and other international market. The drugs currently holds the orphan drug status, and the exclusivity of the drugs in the treatment of the short bowel syndrome would further draw huge revenue during the forecast period.
Browse the full report Short Bowel Syndrome Market: Market Growth, Future Prospects and Competitive Analysis, 2017-2025 at http://www.credenceresearch.com/report/short-bowel-syndrome-market
North America held the largest market in the short bowel syndrome market with U.S. being the highest grossing country. The major factor driving the U.S. short bowel syndrome market is the rising prescription of Gattex, which is the only approve drug in the U.S. Moreover, the increasing demand for growth hormones and glutamine are further driving the short bowel market in the U.S. Europe held the second largest market as in the U.S., approximately 6,000-7,000 SBS patients are dependent on parenteral support with a similar prevalence in Europe. Revestive is the highest grossing drug in the Europe which is marketed by Shire, plc. Moreover, efficient reimbursement scenario in North America and Europe would further drive the market for short bowel syndrome during the forecast period.
Market Competition Assessment:
The short bowel syndrome market comprises large number of pharmaceutical giants operating in the market. Shire holds the largest market share in the short bowel syndrome market. The companies include Merck KGaA, and Emmaus Life Sciences, Inc, Nutrinia Ltd, GlyPharma Therapeutics, OxThera, Ardelyx, Inc, and others.
Browse the full report Short Bowel Syndrome Market: Market Growth, Future Prospects and Competitive Analysis, 2017-2025 at http://www.credenceresearch.com/report/short-bowel-syndrome-market
Key Market Movements:
- Growing prescriptions of Gattex and Revestive in U.S. and Europe respectively is boosting the growth of the short bowel syndrome market.
- Moreover, the increasing demand for growth hormones and glutamine are further driving the short bowel market in the U.S. and Europe.
Latest Report
Flavored Syrups Market
https://www.credenceresearch.com/report/flavored-syrups-market
Corrugated Box Packaging Market
https://www.credenceresearch.com/report/corrugated-box-packaging-market
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290
Email: sales(at)credenceresearch.com
Web: http://www.credenceresearch.com/
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290
Email: sales(at)credenceresearch.com
Web: http://www.credenceresearch.com/
Datum: 06.12.2017 - 05:46 Uhr
Sprache: Deutsch
News-ID 1530063
Anzahl Zeichen: 4570
contact information:
Contact person: jayvir singh
Town:
San Jose
Phone: 8003618290
Kategorie:
Research & Development
Typ of Press Release: Erfolgsprojekt
type of sending: Veröffentlichung
Date of sending: 06/12/2017
Anmerkungen:
Diese Pressemitteilung wurde bisher 524 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Short Bowel Syndrome Market - Growth, Future Prospects and Competitive Analysis, Industry Forecast 2016 – 2025
"
steht unter der journalistisch-redaktionellen Verantwortung von
Credence Research (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
